Carmustine wafer implantation for supratentorial glioblastomas, IDH-wildtype in “extreme” neurosurgical conditions
Article in Neurosurgical Review (June 2023)
The most recent citing publications are shown below. View all 89 publications that cite this research output on Dimensions.
Fibroblast growth factor 2 is a druggable target against glioblastoma: A computational investigation
Article in Frontiers in Chemistry (November 2022)
A Pt(IV)-conjugated brain penetrant macrocyclic peptide shows pre-clinical efficacy in glioblastoma
Article in Journal of Controlled Release (November 2022)